Vaxxinity, Inc. (VAXX)
NASDAQ: VAXX · IEX Real-Time Price · USD
0.718
+0.029 (4.14%)
At close: Mar 28, 2024, 4:00 PM
0.730
+0.012 (1.74%)
After-hours: Mar 28, 2024, 7:41 PM EDT

Vaxxinity Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Cash & Equivalents
5.0434.57145.0631.20.48
Short-Term Investments
25.4653.35000
Cash & Cash Equivalents
30.587.92145.0631.20.48
Cash Growth
-65.31%-39.39%364.96%6454.20%-
Receivables
000.390.390.3
Other Current Assets
2.735.978.854.090.66
Total Current Assets
33.2393.89154.335.671.44
Property, Plant & Equipment
11.0812.5112.3712.160.16
Other Long-Term Assets
0002.310
Total Long-Term Assets
11.0812.5112.3714.470.16
Total Assets
44.31106.4166.6750.141.6
Accounts Payable
12.3618.073.191.021.28
Current Debt
000.3827.5913.19
Other Current Liabilities
5.2512.8723.9310.755.41
Total Current Liabilities
17.6130.9427.4939.3619.88
Long-Term Debt
15.1714.5510.3235.031.12
Other Long-Term Liabilities
-1.87-1.270.240.652.29
Total Long-Term Liabilities
13.313.2810.5635.683.41
Total Liabilities
30.944.2238.0575.0423.29
Total Debt
15.1714.5510.762.6314.31
Debt Growth
4.25%35.98%-82.92%337.68%-
Retained Earnings
-361.64-304.7-229.48-92.31-52.35
Comprehensive Income
0.01-0.2000
Shareholders' Equity
13.4162.18128.62-87.38-48.51
Net Cash / Debt
15.3373.37134.36-31.43-13.83
Net Cash / Debt Growth
-79.10%-45.39%---
Net Cash Per Share
0.120.581.75-0.48-0.26
Working Capital
15.6362.95126.81-3.68-18.44
Book Value Per Share
0.110.491.68-1.33-0.91
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).